According to the current analysis
of Reports and Data, the global Nucleic
Acid Labeling market valued at USD 1.56 billion in 2018 and is
expected to reach USD 3.08 billion by the year 2026, at a CAGR of 8.6%. A wide
variety of molecular and cellular biology procedures are dependent on a labeled
or tagged nucleic acid. These behavior and functioning can be specifically
studied via the attached label. Nucleic acids can be easily labelled with
several tags that allows their detection and purification. These tags can be
used to recover or identify other interacting molecules. The integrity of
the nucleic acid is preserved in this non-destructive reaction, which makes it
useful for applications where it is necessary to use the intact sample.
Owing to the growing demand for
nucleic acid labeling, the manufacturers are adapting strategic initiatives
such as innovative launch systems to increase their product portfolio. For
example, with the launch of PHOTOPROBE labeling systems, the total length of
the original nucleic acid sample, instead of copies, is directly marked.
Additionally, Nucleic Acid Labeling can also be used for applications involving
protein interactions, such as gel change or drip analysis, it is generally
advantageous to generate labeled probes at the end to avoid steric interference
of the interaction. The nucleic acid transfer can provide valuable information
on gene integrity and copy number, as well as a means of analyzing mRNA size
and expression gene, nucleic acid labeling helps to characterize cells and
tissues developed in vitro and often produce important clinical information
when used in patient samples. Moreover, the availability of different labels
and a wide range of detection systems improve the sensitivity and flexibility
required for in situ hybridization, thus, eventually driving the market growth
for nucleic acid labeling.
Personalized medicine aims to
provide personalized treatments to each patient based on the molecular basis of
the disease, which has become popular in recent years. The patient centric
approach is increasing day by day. The rise in geriatric population all across
the world and the increasing prevalence of chronic diseases are factors that
put constant pressure on the capacity and financial sustainability of health
systems around the world. Personalized medicine promises to provide better
patient care and a high margin of safety while reducing total health care
costs. However, lack of awareness about the healthcare facilities, high cost
and lack of professional and skilled training provided to healthcare
professionals are the major hindrances for market growth during the forecast
period.
To identify the key trends in
the industry, click on the link below:
No comments:
Post a Comment